J. Michael Edwards's Insider Trades & SAST Disclosures
J. Michael Edwards's most recent trade in BioAffinity Technologies Inc was a trade of 6,172 Common Stock done . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Michael Edwards.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAffinity Technologies Inc | J. Michael Edwards | VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 6,172 | 120,128 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | J. Michael Edwards | VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 100,000 | 113,956 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,619 | 36,815 | - | 0 | Common Stock, par value $0.007 | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Sep 2022 | 2,448 | 30,323 | - | - | Common Stock, par value $0.007 | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Sep 2022 | 2,448 | 2,448 | - | - | Non-tradeable Warrants (right to buy) | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Sep 2022 | 2,448 | 2,448 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | 01 Sep 2022 | 2,243 | 32,566 | - | 4.2 | 9,421 | Common Stock, par value $0.007 | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 1,903 | 1,903 | - | - | Warrant (right to buy) | |
| BioAffinity Technologies Inc | J. Michael Edwards | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 761 | 761 | - | - | Warrant (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges